National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

This grant funds investigator-initiated early-phase (Phase 0, I, II) clinical trials of cancer-targeted diagnostic or therapeutic interventions. Projects must include at least one trial aligned with NCI research programs such as Cancer Therapy Evaluation, Cancer Imaging, Cancer Diagnosis, Radiation Research, Complementary and Alternative Medicine, or HIV/AIDS Malignancies.

Amount: up to $499,999
Type: Grant

Key facts

Key facts for National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Amount	up to $499,999
Issuer	National Institutes of Health
Who can apply	Small businesses, companies, universities and 7 more
Sectors	EdTech · HealthTech
Deadline	Closes 07 Jan 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 2 days ago

85 days agoagentImported from the official source

Opportunities with the same funding type or region
European Degree Exploratory Action		Closes 18 Feb 2027
Cooperative Agreement for affiliated Partner with Alaska Cooperative Ecosystem Studies Unit	up to $234,460	Closes 07 Dec 2026
Cooperative Agreement for affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unit	up to $150,000	Closes 07 Dec 2026